These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19367089)

  • 41. The value of using top-down and bottom-up approaches for building trust and transparency in biobanking.
    Meslin EM
    Public Health Genomics; 2010; 13(4):207-14. PubMed ID: 20395689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A framework for assessing the quality of democratic deliberation: enhancing deliberation as a tool for bioethics.
    De Vries R; Stanczyk AE; Ryan KA; Kim SY
    J Empir Res Hum Res Ethics; 2011 Sep; 6(3):3-17. PubMed ID: 21931233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Informing public health policy through deliberative public engagement: perceived impact on participants and citizen-government relations.
    Molster C; Potts A; McNamara B; Youngs L; Maxwell S; Dawkins H; O'Leary P
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):713-8. PubMed ID: 23862565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Confidentiality, informed consent, and children's participation in research involving stored tissue samples: interviews with medical professionals from the Middle East.
    Alahmad G; Al Jumah M; Dierickx K
    Narrat Inq Bioeth; 2015; 5(1):53-66. PubMed ID: 25981282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].
    Boeckhout M; van Dijk J; Legemate DA
    Ned Tijdschr Geneeskd; 2011; 155(26):A3557. PubMed ID: 21767425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The human face of biobank networks for translational research.
    Meir K; Gaffney EF; Simeon-Dubach D; Ravid R; Watson PH; Schacter B; Morente And The Marble Arch International Working Group On Biobanking MM
    Biopreserv Biobank; 2011 Sep; 9(3):279-85. PubMed ID: 24850340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Theatre as a public engagement tool for health-policy development.
    Nisker J; Martin DK; Bluhm R; Daar AS
    Health Policy; 2006 Oct; 78(2-3):258-71. PubMed ID: 16337306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).
    Matzke EA; O'Donoghue S; Barnes RO; Daudt H; Cheah S; Suggitt A; Bartlett J; Damaraju S; Johnston R; Murphy L; Shepherd L; Mes-Masson AM; Schacter B; Watson PH
    Biopreserv Biobank; 2012 Oct; 10(5):426-32. PubMed ID: 24845043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neglected ethical issues in biobank management: Results from a U.S. study.
    Cadigan RJ; Lassiter D; Haldeman K; Conlon I; Reavely E; Henderson GE
    Life Sci Soc Policy; 2013 Dec; 9(1):1. PubMed ID: 25401081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From engaging publics to engaging knowledges: Enacting "appropriateness" in the Austrian biobank infrastructure.
    Goisauf M; Durnová AP
    Public Underst Sci; 2019 Apr; 28(3):275-289. PubMed ID: 30324869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The reported impact of public involvement in biobanks: A scoping review.
    Luna Puerta L; Kendall W; Davies B; Day S; Ward H
    Health Expect; 2020 Aug; 23(4):759-788. PubMed ID: 32378306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health technology adoption and the politics of governance in the UK.
    Milewa T
    Soc Sci Med; 2006 Dec; 63(12):3102-12. PubMed ID: 16982120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deliberation on Childhood Vaccination in Canada: Public Input on Ethical Trade-Offs in Vaccination Policy.
    O'Doherty KC; Crann S; Bucci LM; Burgess MM; Chauhan A; Goldenberg MJ; McMurtry CM; White J; Willison DJ
    AJOB Empir Bioeth; 2021; 12(4):253-265. PubMed ID: 34328070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Governance and measures for the ethical and social aspects of biobanks].
    Iwae S; Masui T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):493-7. PubMed ID: 22504670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Avoiding empty rhetoric: engaging publics in debates about nanotechnologies.
    Kyle R; Dodds S
    Sci Eng Ethics; 2009 Mar; 15(1):81-96. PubMed ID: 18825510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ethics of research using biobanks: reason to question the importance attributed to informed consent.
    Hoeyer K; Olofsson BO; Mjörndal T; Lynöe N
    Arch Intern Med; 2005 Jan; 165(1):97-100. PubMed ID: 15642883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A proposed approach to informed consent for biobanks in China.
    Liu M; Hu Q
    Bioethics; 2014 May; 28(4):181-6. PubMed ID: 22762502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns.
    Tupasela A; Sihvo S; Snell K; Jallinoja P; Aro AR; Hemminki E
    Scand J Public Health; 2010 Feb; 38(1):46-52. PubMed ID: 19906772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.